NASDAQ:BYSI - BeyondSpring Inc.
$16.22
 $-0.11
-0.67%
4:00PM EDT
2019-07-22
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase II/III clinical trial for the prevention of non-docetaxel chemotherapy-induced severe, grade 4 neutropenia, and a Phase III clinical trial as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). Plinabulin has also entered in a Phase I/II clinical trials to investigate its therapeutic potential in combination with the immuno-oncology agent nivolumab.The Company's product, Plinabulin, is a marine derived small-molecule with a range of biological activities. Plinabulin targets cells in the tumor vasculature resulting in selective anti-tumor activity. Plinabulin has also demonstrated a range of immuno-stimulatory effects, including stimulating the maturation of dendritic cells, increasing cytokine secretion, down regulating inhibitory T-cells, and stimulating tumor-antigen-specific T-cell activation. The Company's BPI-002 program is based on an oral small molecule agent, which induces T-cell activation. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BYSI     avg for
industry  
  avg for
sector  
42 stocks weight:  53. 13   217. 37   399. 45  
42 stocks rank:  2. 35 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  0. 10   5. 49   1. 88  
current ratio:  0. 18   5. 87   2. 36  

target price low:  41. 00   83. 44   114. 90  
target price avg:  41. 00   106. 20   137. 90  
target price high:  41. 00   132. 30   158. 97  
1-yr high:  26. 40   111. 86   142. 57  
last close:  16. 33   86. 79   125. 44  
50-day avg:  18. 35   86. 68   122. 63  
200-day avg:  18. 71   89. 22   121. 38  
1-yr low:  13. 36   69. 78   100. 51  
volume:  88. 21 K 2. 62 M 3. 43 M
50-day avg volume:  76. 19 K 3. 20 M 4. 16 M
200-day avg volume:  24. 60 K 2. 99 M 4. 75 M

1-day return:  1. 74 % -1. 30 % -0. 99 %
this week return:  -21. 11 % 0. 45 % -0. 20 %
12-wk return:  15. 41 % 0. 94 % 4. 84 %
52-wk return:  -37. 79 % -1. 30 % 10. 55 %

enterprise value (EV):  380. 90 M 45. 10 B 122. 38 B
market cap:  390. 38 M 38. 96 B 108. 40 B
EBITDA:  -50. 65 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -7. 52   5. 38   11. 93  
total debt:  6. 44 M 10. 90 B 17. 48 B
net income (common):  -48. 51 M 2. 07 B 4. 05 B

shares outstanding:  23. 18 M 538. 09 M 1. 24 B
shares:  6. 39 M 548. 00 M 1. 22 B
shares short:  355. 73 K 10. 98 M 11. 87 M
shares short prior month:  244. 17 K 9. 32 M 12. 05 M
short ratio:  3. 89   5. 60   3. 34  
short % of float:  3. 24 % 6. 48 % 2. 64 %
total cash/share:  0. 09   10. 98   9. 19  
total cash:  1. 96 M 5. 93 B 6. 10 B
free cash flow:  -16. 34 M 2. 92 B 4. 55 B
operating cash flow:  -36. 08 M 3. 80 B 5. 78 B

book value:  -0. 64   13. 35   27. 45  
price/book:  -25. 52   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 12   2. 10   4. 23  
forward EPS:  -1. 37   3. 45   7. 10  
P/E:  -7. 70   1. 90   32. 10  
forward P/E:  -11. 92   6. 46   15. 47  
PE/G:  2. 30   0. 70   -0. 54  
growth:  -3. 35 % 265. 63 % 79. 11 %
earnings high:  -0. 27   0. 89   1. 68  
earnings avg:  -0. 27   0. 70   1. 57  
earnings low:  -0. 27   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -199. 73 % -2. 34 % 5. 28 %
return on equity:  -9673. 28 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  -0. 07   1. 27   0. 91  
sharpe (1yr):  -0. 48   0. 16   0. 77  

held % insiders:  77. 22 % 6. 06 % 3. 29 %
held % institutions:  1. 39 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : BYSI
.    122.718 =       122.718 :: --> INITIAL WEIGHT <--
.    - 2.121 =       120.597 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.199 =       265.157 :: P/E factor
.    x 0.932 =       247.085 :: PE/G factor
.    x 1.442 =       356.234 :: beta factor
.     x 0.81 =       288.434 :: sharpe factor
.    x 2.031 =       585.863 :: current ratio factor
.    x 1.433 =       839.785 :: quick ratio factor
.    x 1.121 =       941.559 :: short ratio factor
.                               --> PERFORMANCE <--
.    x 2.121 =      1996.852 :: sector+industry 1-year gains factor
.    x 1.009 =      2015.679 :: industry 12-weeks return factor
.    x 1.308 =      2636.283 :: industry 2-weeks return factor
.    x 0.918 =      2418.979 :: company one-year gains+dividend factor
.    x 2.566 =      6206.779 :: company 13 weeks' performance factor
.    x 0.962 =      5971.811 :: "drift" penalty 1 days ago
.    x 0.943 =        5632.9 :: "drift" penalty 3 days ago
.    x 0.968 =      5453.657 :: "drift" penalty 4 days ago
.    / 2.059 =       2648.77 :: overall "drift" factor
.    x 0.768 =      2033.269 :: largest single-day jump factor
.        x 1 =      2033.269 :: volatility factor
.        x 1 =      2033.269 :: 42-day volatility factor
.     x 2.51 =      5102.828 :: notable returns + performance factor
.    x 3.103 =     15834.632 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.905 =     14324.797 :: forward EPS factor
.    x 0.965 =     13828.466 :: forward P/E factor
.    x 1.185 =     16382.757 :: industry recommendation factor
.    x 2.068 =     33886.968 :: company recommendation factor
.    x 1.003 =     33980.679 :: factor historical industry gain for week 29
.   x 11.437 =    388639.945 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        24.968 :: reduced for readability
.   + 28.165 =        53.133 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     53.133 :: FINAL WEIGHT for NASDAQ:BYSI


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org